Accessibility Menu
DarioHealth logo

DarioHealth(NASDAQ) DRIO

Market Cap$71.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-100%
5 Year-98%
1 Year-37%
1 Month+8%
$7.30
+1.39%
+0.10Today
DarioHealth last closing stock price
MetricPriceDate
Last closeUSD 7.272026-07-31
DarioHealth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-6.68%USD 7.792026-07-24
1 month+7.7%USD 6.752026-07-01
3 month-0.41%USD 7.302026-05-01
Year to date-36.12%USD 11.382025-12-31
1 year-36.56%USD 11.462025-07-31
3 year-90.12%USD 73.602023-08-01
5 year-97.55%USD 296.802021-07-30
Since inception-99.99%USD 89,640.252013-04-09

DarioHealth Financials at a Glance

Market Cap

$71.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$21.19M

Net Income (TTM)

$62.71M

EPS (TTM)

-$10.58

P/E Ratio

-0.69

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$7.30

Volume

7,373

Open

$7.50

Previous Close

$7.27

Daily Range

$7.01 - $7.50

52-Week Range

$5.84 - $17.74

Estimated Earnings Date

Aug 11, 2026

DRIO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DarioHealth

DarioHealth helps people manage chronic health conditions using digital tools. Its products support diabetes, high blood pressure, and mental health needs. Users track health data, get coaching, and access care from home.

Products and Services

  • Metabolic Solutions: Digital programs for diabetes, hypertension, and weight management; targets individuals and employers.
  • Musculoskeletal (MSK) Care: Digital support for joint and muscle pain; included in bundled offerings for employers and health plans.
  • Behavioral Health: Online mental health tools and coaching; part of integrated care for stress, anxiety, and depression.
  • Connected Devices: Smart glucose meters, blood pressure cuffs, and digital scales; used for real-time health tracking.
  • DarioEngage Platform: Central software for care management, data analysis, and user engagement; supports both direct consumers and business clients.

Growth and Expansion

  • Acquired Twill in 2024, adding behavioral health and engagement technology.
  • Formed partnership with OneStep in October 2025 for fall-risk and mobility insights.
  • Launched DarioIQ (AI personalization) and DarioSHIFT (AI efficiency) in 2025.
  • Expanded GLP-1 weight management programs for employers and pharmaceutical partners in 2025.
  • Entered Australia, New Zealand, and European Union markets before 2025, broadening international reach.

What Makes DarioHealth Stand Out

DarioHealth combines hardware, software, and coaching for a full-service approach to chronic care. Its platform uses artificial intelligence trained on billions of data points for personalized support. The company offers bundled solutions, reducing complexity for employers and health plans.

Five Things You Need to Know

  • 2025 revenue was $22.36 million, down 17.3% from 2024.
  • Gross margin rose to 56.6% in 2025, up from 49.1% in 2024.
  • Operating loss improved to $36.66 million in 2025, from $57.74 million in 2024.
  • Employer customers grew to 167 in 2025, up from 53 in 2024.

Bottom Line

DarioHealth has shifted from direct-to-consumer roots to a broader business focus. Its integrated digital health platform supports multiple chronic conditions for individuals and organizations.

AI Generated • Apr 16, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

165

CEO

Erez Raphael

Website

www.dariohealth.com

Headquarters

New York City, NY 10011, US

DRIO Financials

Key Financial Metrics (TTM)

Gross Margin

56.55%

Operating Margin

-251.87%

Net Income Margin

295.94%

Return on Equity

93.18%

Return on Capital

-36.78%

Return on Assets

60.72%

Earnings Yield

-1.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$71.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

9.79M

Volume

7.37K

Avg. Volume

12.65K

Financials (TTM)

Gross Profit

$11.98M

Operating Income

-$53.37M

EBITDA

-$32.19M

Operating Cash Flow

-$25.29M

Capital Expenditure

-$142.00K

Free Cash Flow

-$25.44M

Cash & ST Invst.

$20.26M

Total Debt

$31.82M

DarioHealth Performance Analysis

DarioHealth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 27,656,00034.8%
20232023-12-31USD 20,352,000-26.4%
20242024-12-31USD 27,040,00032.9%
20252025-12-31USD 22,359,000-17.3%
DarioHealth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-20.5%
Q32025-09-30-6.7%
Q42025-12-314.5%
Q12026-03-316.7%
DarioHealth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -50.74-46.6%
20232023-12-31USD -38.67-23.8%
20242024-12-31USD -12.27-68.3%
20252025-12-31USD -10.12-17.5%
DarioHealth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-242.9%
Q32025-09-30290.0%
Q42025-12-31400.0%
Q12026-03-31-34.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$5.58M

-17.3%

Gross Profit

$3.20M

-17.6%

Gross Margin

57.31%

N/A

Market Cap

$71.20MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$431.50K

N/A

Employees

165

N/A

Net Income

-$8.25M

+10.6%

EBITDA

-$6.52M

+20.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$20.26M

-27.2%

Total Debt

$31.82M

+4.9%

Accounts Receivable

$2.22M

-62.4%

Inventory

$4.17M

-9.7%

Long Term Debt

$31.44M

+60.8%

Short Term Debt

$378.00K

-96.5%

Return on Assets

60.72%

N/A

Return on Invested Capital

-56.83%

N/A

Free Cash Flow

-$6.06M

+9.7%

Operating Cash Flow

-$6.03M

+9.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MYGNMyriad Genetics, Inc.
$2.86-46.74%
NNNNAnbio Biotechnology Class A Ordinary Shares
$9.90-7.91%
PACBPacific Biosciences of California, Inc.
$1.40-5.41%
FLGTFulgent Genetics, Inc.
$16.55-18.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About DRIO

What is the current price of DarioHealth?

DarioHealth is trading at $7.27 per share.

What is the 52-week range for DarioHealth?

Over the past 52 weeks, DarioHealth has traded between $5.84 and $17.74.

How much debt does DarioHealth have?

As of the most recent reporting period, DarioHealth reported total debt of $31.82M.

How much cash does DarioHealth have on hand?

DarioHealth reported $20.26M in cash and cash equivalents in its most recent financial results.

What is DarioHealth’s dividend yield?

DarioHealth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services